Most people stop eventually — because of cost, side effects, supply, or because they reached the number they wanted. What the trials consistently show is that weight comes back, and the part almost nobody is told is that what comes back is not the same as what went. In midlife that distinction matters more than it does at thirty.

Where we stand: Menova is an independent publication. We sell no medication and no programmes, we are not your doctor, and this is general education, not medical advice. Do not stop, start or change a prescription based on this page.

Regain is the expected result, not a personal failure

Across the trials, stopping is followed by substantial regain over the following year — often most of what was lost. Appetite returns, and it returns to roughly where it was.

That is worth saying plainly because most people experience it as their own collapse of willpower. It is the predictable behaviour of the drug ending, in the same way blood pressure rises again when a blood pressure medication is stopped. Nobody frames that as a failure of character.

Which is why "a course you complete" is the wrong model. These work while they are taken — see GLP-1s in perimenopause.

The part that matters in midlife

Weight lost on any substantial deficit is fat plus lean tissue. Weight regained afterwards is disproportionately fat.

So a cycle of losing and regaining the same number of kilograms can leave you with less muscle and more fat at the same weight than you started with. Repeat that a few times and the body composition moves in one direction only.

That is true for anyone. It matters more here because muscle is already declining in this decade, and because muscle is where a great deal of glucose disposal happens — see muscle loss in midlife and insulin resistance in menopause.

Bone is the other one. Rapid weight loss is associated with bone loss, and the years around menopause are when bone loss is fastest anyway — see bone health in menopause.

What actually changes the outcome

Not a different drug, and not willpower. Two things, and they need to be in place before you stop.

Resistance training, twice a week, throughout. This is the single intervention that protects lean mass during loss and gives the regain somewhere better to go. It matters more on these medications, not less — see strength training in menopause and starting from zero.

Enough protein, throughout. Appetite suppression makes it easy to undereat protein specifically, which is exactly the wrong thing to under-eat while losing weight — see how much protein you need.

If you did neither while taking it, that is worth knowing before you stop rather than after.

Why people stop, and what each one actually needs

Cost. The commonest reason. Worth asking about lower maintenance doses, and about whether a cheaper approved product is available to you, before stopping outright — see the cost of care.

Side effects. Often dose-related. A slower titration or a lower maintenance dose is a conversation, not a reason to abandon it — see semaglutide versus tirzepatide.

"I've reached my goal." This is the one that most reliably ends in regain, because nothing about the underlying regulation changed. Ask specifically about a maintenance dose rather than stopping.

Supply, or a compounded source disappearing. The regulatory position on compounded GLP-1s has tightened considerably; a supply that vanishes is not the same as a treatment that failed — see how to get a GLP-1 online.

Pregnancy, or planning one. These are not used in pregnancy. If there is any chance, raise it — fertility in the forties is reduced, not absent; see am I pregnant, or is this perimenopause.

If you are going to stop

Do it as a plan rather than an event.

  • Talk to the prescriber first. Ask whether tapering or a maintenance dose is appropriate for you rather than stopping outright
  • Have the training and the protein already running for a month or two beforehand
  • Expect appetite to return, and decide in advance what you will do when it does. It is not a signal that something has gone wrong
  • Weigh less often, not more. The number will move; watching it daily reliably makes this harder
  • Keep the midlife numbers under review — blood pressure, lipids, HbA1c — because those are the reason any of this matters; see which tests to ask for and our free blood test sheet
  • Do not switch to a compounded version to save money. The regulatory and safety picture is different, and it is not the equivalent product; see compounded versus FDA-approved

What this is not

Not a reason to avoid them. For some people these medications are genuinely the right treatment, and the fact that stopping reverses the effect is true of most medications.

Not a reason to stay on them at any cost. Deciding they are not worth it to you is legitimate, and it is a better decision made with the regain expected rather than as a surprise.

And not a substitute for the things that work regardless — see losing weight in midlife and weight and energy in midlife.

What to say

"I'm thinking about stopping — mainly the cost. Before I do, is a lower maintenance dose an option? And what should I have in place first so I keep as much muscle as possible?"

That names the actual reason, asks for the alternative most people do not know exists, and puts the muscle question on the table before it becomes a problem rather than after.

Our free 30-day symptom tracker and free printable visit prep sheet keep the appointment short, and the free 2-minute Menova self-check organizes your wider symptom picture — no account, not a diagnosis, and your answers never leave your device.

This article is general education, not medical advice. Do not stop, start, or change any prescription based on this page — discuss it with the clinician who prescribed it. Seek prompt assessment for severe abdominal pain, persistent vomiting, or signs of dehydration.

Sources: NIDDK — Prescription Medications to Treat Overweight and Obesity, FDA — Postmarket Drug Safety Information, NICE NG23 — Menopause, and NHS — Semaglutide.